Skip to content

Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

Engagement and Clinical Impact of the Teleo Virtual Therapy Platform

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06364137
Enrollment
41
Registered
2024-04-15
Start date
2024-07-01
Completion date
2025-09-15
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Mood Disorders

Brief summary

The research study will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the pilot trial will examine examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Detailed description

The research study will examine engagement in telehealth for children undergoing psychotherapy. The study in Phase I entails a pilot randomized trial with a goal to enroll 42 families, examining patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing. Engagement will be assessed using well-established measures - PRIME-O (modified) video coding (session 1), MTT-Y/MTTCG (sessions 1, 4) and attendance data (sessions 1-4). Clinicians in the study will deliver therapy to clients for 4 sessions, providing opportunity to measure temporal sustainment of any engagement differences.

Interventions

Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform

OTHERTeleo

Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
MainSquare Co. (dba 'Teleo')
CollaboratorUNKNOWN
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* Receiving psychotherapy with a licensed professional on the Teleo platform * Likely have at least 12 sessions remaining. * Diagnosis of a mental health condition by a licensed clinician

Exclusion criteria

* Not under treatment with provider using Teleo platform

Design outcomes

Primary

MeasureTime frameDescription
PRIME-O Video Coding ScoreWeeks 1, 2, 3, 4Assess therapeutic engagement using modified PRIME-O total score, group scores, and individual item sub-scores. Scores range from 0-40, higher scores indicate 'better' outcome.

Secondary

MeasureTime frameDescription
My Thoughts about Therapy - Caregiver (MTT-CG) engagement questionnaire scoresPost-intervention (at one month)Caregivers will complete modified MTT-CG questionnaire to measure engagement across dimensions of the REACH client engagement framework - Relationship, Expectancy, Attendance, Clarity, and Homework. Scores range from 0-105, higher scores indicate 'better' outcome.
My Thoughts about Therapy - Youth (MTT-Y) engagement questionnaire scoresPost-intervention (at one month)Youth will complete questionnaires to measure self-reported engagement across dimensions of the REACH client engagement framework - Relationship, Expectancy, Attendance, Clarity, and Homework. Scores range from 0-105, higher scores indicate 'better' outcome.
Attendance during Psychotherapy SessionsOne monthInstances and frequency of appointment cancellations, appointment no-shows, and/or discontinuation of therapy will be recorded and analyzed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026